Apyx Medical Corp
(APYX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,559 | -18,850 | -23,278 | -15,200 | -11,906 |
| Depreciation Amortization | 599 | 692 | 890 | 903 | 887 |
| Accounts receivable | -2,035 | -3,574 | 1,918 | -4,901 | -558 |
| Accounts payable and accrued liabilities | -63 | 25 | 67 | 1,154 | -965 |
| Other Working Capital | -1,245 | 5,543 | -5,217 | -1,843 | -10,253 |
| Other Operating Activity | 8,256 | 10,915 | 5,340 | 9,438 | 6,729 |
| Operating Cash Flow | $-18,047 | $-5,249 | $-20,280 | $-10,449 | $-16,066 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -722 | 6,734 | -1,010 | -723 | -581 |
| Investing Cash Flow | $-722 | $6,734 | $-1,010 | $-723 | $-581 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 2,632 | N/A | N/A | N/A |
| Debt Issued | N/A | 43,474 | N/A | N/A | N/A |
| Debt Repayment | -20 | -37 | -148 | -238 | -369 |
| Common Stock Issued | N/A | 86 | 365 | 67 | 148 |
| Other Financing Activity | 6,765 | -13,989 | 0 | 195 | 148 |
| Financing Cash Flow | $6,745 | $32,166 | $217 | $24 | $-73 |
| Exchange Rate Effect | 113 | -191 | 395 | 103 | -177 |
| Beginning Cash Position | 43,652 | 10,192 | 30,870 | 41,915 | 58,812 |
| End Cash Position | 31,741 | 43,652 | 10,192 | 30,870 | 41,915 |
| Net Cash Flow | $-11,911 | $33,460 | $-20,678 | $-11,045 | $-16,897 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,047 | -5,249 | -20,280 | -10,449 | -16,066 |
| Capital Expenditure | -722 | -533 | -1,010 | -723 | -581 |
| Free Cash Flow | -18,769 | -5,782 | -21,290 | -11,172 | -16,647 |